Tandem Diabetes Care reported earnings of -$ 0.10 per TNDM share on Nov 5, 2026, falling short of analysts' expectations by
| Report Date | Nov 5, 2026 |
|---|---|
| Forecasted EPS | -$ 0.25 |
| Earnings Per Share (Surprise) | -$ 0.10 (+$ 0.1453) |
| Last Year's EPS | -$ 0.37 |
| EPS YoY Change |
Out of the last 56 earnings reporting periods, Tandem Diabetes Care beat analysts’ expectations 28 times and fell short of expectations 23 time(s). Tandem Diabetes Care reported earnings per share of -$ 0.10 in the last report surpassing an estimated EPS of -$ 0.25 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 5, 2026 | -$ 0.25 | -$ 0.10 | -$ 0.31 | |
| Aug 6, 2026 | -$ 0.32 | -$ 0.31 | -$ 0.48 | |
| May 7, 2026 | -$ 0.46 | -$ 0.30 | -$ 0.67 | |
| Feb 19, 2026 | -$ 0.05 | -$ 0.01 | $ 0.01 | |
| Nov 6, 2025 | -$ 0.31 | -$ 0.31 | -$ 0.35 | |
| Aug 6, 2025 | -$ 0.40 | -$ 0.48 | -$ 0.48 | |
| Apr 30, 2025 | -$ 0.60 | -$ 0.67 | -$ 0.63 | |
| Feb 26, 2025 | -$ 0.23 | $ 0.01 | -$ 0.27 | |
| Nov 6, 2024 | -$ 0.40 | -$ 0.35 | -$ 0.38 | |
| Aug 1, 2024 | -$ 0.54 | -$ 0.48 | -$ 0.55 | |
| May 2, 2024 | -$ 0.76 | -$ 0.63 | -$ 1.92 | |
| Feb 21, 2024 | -$ 0.25 | -$ 0.27 | -$ 0.01 | |
| Nov 1, 2023 | -$ 0.34 | -$ 0.38 | -$ 0.76 | |
| Aug 3, 2023 | -$ 0.54 | -$ 0.55 | -$ 0.24 | |
| May 3, 2023 | -$ 0.56 | -$ 1.92 | -$ 0.23 | |
| Feb 22, 2023 | -$ 0.02 | -$ 0.01 | $ 0.16 | |
| Nov 2, 2022 | -$ 0.05 | -$ 0.76 | $ 0.09 | |
| Aug 3, 2022 | $ 0.02 | -$ 0.24 | $ 0.06 | |
| May 4, 2022 | -$ 0.07 | -$ 0.23 | -$ 0.08 | |
| Feb 22, 2022 | $ 0.21 | $ 0.16 | $ 0.22 |
Tandem Diabetes Care’s stock was trading at $ 19.05 on Nov 4, 2026 a day before the last earnings report was released.Following the release of the earnings report, TNDM’s price decreased to $ 16.91 on Nov 6, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 5, 2026 | -$ 0.10 | $ 19.05 | $ 16.91 | |
| Aug 6, 2026 | -$ 0.31 | $ 19.59 | $ 22.38 | |
| May 7, 2026 | -$ 0.30 | $ 18.03 | $ 15.48 | |
| Feb 19, 2026 | -$ 0.01 | $ 18.94 | $ 24.57 | |
| Nov 6, 2025 | -$ 0.31 | $ 14.67 | $ 16.26 | |
| Aug 6, 2025 | -$ 0.48 | $ 15.15 | $ 11.52 | |
| Apr 30, 2025 | -$ 0.67 | $ 16.77 | $ 19.98 | |
| Feb 26, 2025 | $ 0.01 | $ 33.34 | $ 21.75 | |
| Nov 6, 2024 | -$ 0.35 | $ 33.11 | $ 33.32 | |
| Aug 1, 2024 | -$ 0.48 | $ 36.98 | $ 41.67 | |
| May 2, 2024 | -$ 0.63 | $ 36.20 | $ 44.72 | |
| Feb 21, 2024 | -$ 0.27 | $ 23.56 | $ 25.00 | |
| Nov 1, 2023 | -$ 0.38 | $ 17.30 | $ 15.20 | |
| Aug 3, 2023 | -$ 0.55 | $ 32.50 | $ 33.41 | |
| May 3, 2023 | -$ 1.92 | $ 38.62 | $ 37.51 | |
| Feb 22, 2023 | -$ 0.01 | $ 39.00 | $ 38.17 | |
| Nov 2, 2022 | -$ 0.76 | $ 56.00 | $ 36.77 | |
| Aug 3, 2022 | -$ 0.24 | $ 68.15 | $ 58.60 | |
| May 4, 2022 | -$ 0.23 | $ 95.92 | $ 80.22 | |
| Feb 22, 2022 | $ 0.16 | $ 104.51 | $ 104.20 |
Tandem Diabetes Care released its most recent earnings reports in November 2026, August 2026, May 2026, February 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Tandem Diabetes Care beat analysts’ expectations during the last earnings period by
